Implementation of QbD based Control Strategy during Drug Product Continuous Manufacturing

09:15 - 09:50

novartis.png

 

  • Which QbD elements are used throughout the product development in CM
  • Strategy to identify Critical Process Parameters and Critical Material Attributes
  • Implementing the appropriate Control Strategy and keeping the process in a state of control

Frantz Elbaz, Formulator Project Leader and Pharm Development QBD Network Leader, Novartis